{
    "2020-09-14": [
        [
            {
                "time": "2020-09-15",
                "original_text": "Warren Buffett: Opportunity Cost in Times of Uncertainty",
                "features": {
                    "keywords": [
                        "Warren Buffett",
                        "Opportunity Cost",
                        "Uncertainty"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-09-16",
                "original_text": "AstraZeneca resumes COVID-19 vaccine trial",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "COVID-19",
                        "vaccine",
                        "trial"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-17",
                "original_text": "Johnson & Johnson Kicks Off Phase 2 Covid-19 Vaccine Trial In Spain â€“ Report",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Phase 2",
                        "Covid-19",
                        "Vaccine",
                        "Trial",
                        "Spain"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-18",
                "original_text": "J&J unit to start mid-stage COVID-19 vaccine trials in Spain",
                "features": {
                    "keywords": [
                        "J&J",
                        "unit",
                        "mid-stage",
                        "COVID-19",
                        "vaccine",
                        "trials",
                        "Spain"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}